Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 03:00PM GMT
Release Date Price: $203.17 (-0.14%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

Hi, everybody. I see the clock is already running. So we better get started. I'm Dave Windley with Jefferies Healthcare Equity Research based here in the States in, actually, Nashville, Tennessee. Welcome you all down to visit us for [Bryan's] bus tour later in the summer. But for now, we're here at our New York Global Healthcare Conference.

Appreciate your attendance there and are here and also appreciate Charles River's participation. Birgit Girshick, the company's COO, is with me here to talk fireside. And so we'll get into questions. He's had busy day already and more to come. So I want to start Birgit, again thanks for being here.

Questions & Answers

David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

I want to start just talking about the variety of drivers of growth and the biggest segment, Discovery and Safety Assessment, probably is the logical place to start. So the company has built a very substantial backlog, much longer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot